Literature DB >> 2985506

Inhibition of growth of Chlamydia trachomatis by human gamma interferon.

Y Shemer, I Sarov.   

Abstract

Treatment of HEp-2 cell cultures with highly purified human gamma interferon before infection resulted in the reduction of Chlamydia trachomatis (L2/434/Bu) infectious particle yield. Electron microscope studies showed that interferon did not affect chlamydial conversion to reticulate bodies but influenced the extent of maturation to elementary bodies. High interferon concentrations (greater than 350 IU/ml) inhibited inclusion body formation and resulted in the appearance of aberrant reticulate bodies.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2985506      PMCID： PMC261392          DOI： 10.1128/iai.48.2.592-596.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  14 in total

1.  The growth cycle of the psittacosis group of micro-organisms.

Authors:  J LITWIN
Journal:  J Infect Dis       Date:  1959 Sep-Oct       Impact factor: 5.226

2.  RNA in the elementary bodies of trachoma agent.

Authors:  I Sarov; Y Becker
Journal:  Nature       Date:  1968-03-02       Impact factor: 49.962

3.  Trachoma agent DNA.

Authors:  I Sarov; Y Becker
Journal:  J Mol Biol       Date:  1969-06-28       Impact factor: 5.469

4.  Adenosine Triphosphate and Other Requirements for the Utilization of Glucose by Agents of the Psittacosis-Trachoma Group.

Authors:  E Weiss
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

5.  Toxicity of low and moderate multiplicities of Chlamydia psittaci for mouse fibroblasts (L cells).

Authors:  K R Kellogg; K D Horoschak; J W Moulder
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

6.  Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin.

Authors:  G I Byrne; D A Krueger
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

7.  Determination of specific IGA antibodies to varicella zoster virus by immunoperoxidase assay.

Authors:  H Haikin; I Sarov
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

8.  Interaction of L cells and Chlamydia psittaci: entry of the parasite and host responses to its development.

Authors:  R R Friis
Journal:  J Bacteriol       Date:  1972-05       Impact factor: 3.490

9.  Chlamydia trachomatis associated with chronic inflammation in abdominal specimens from women selected for tuboplasty.

Authors:  J Henry-Suchet; F Catalan; V Loffredo; M J Sanson; C Debache; F Pigeau; R Coppin
Journal:  Fertil Steril       Date:  1981-11       Impact factor: 7.329

10.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441
View more
  65 in total

Review 1.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

2.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

Review 3.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

4.  Peptidomic analysis of human peripheral monocytes persistently infected by Chlamydia trachomatis.

Authors:  Birgit Krausse-Opatz; Annette Busmann; Harald Tammen; Christoph Menzel; Thomas Möhring; Nicolas Le Yondre; Cornelia Schmidt; Peter Schulz-Knappe; Henning Zeidler; Hartmut Selle; Lars Köhler
Journal:  Med Microbiol Immunol       Date:  2007-01-06       Impact factor: 3.402

5.  Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Authors:  J U Igietseme; I M Uriri; S N Kumar; G A Ananaba; O O Ojior; I A Momodu; D H Candal; C M Black
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

7.  Cell Intrinsic Factors Modulate the Effects of IFNγ on the Development of Chlamydia trachomatis.

Authors:  Shardulendra Sherchand; Joyce A Ibana; Alison J Quayle; Ashok Aiyar
Journal:  J Bacteriol Parasitol       Date:  2016-07-25

8.  Production of alpha interferon in Cowdria ruminantium-infected cattle and its effect on infected endothelial cell cultures.

Authors:  P Totté; F Jongejan; A L de Gee; J Wérenne
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract.

Authors:  H Su; H D Caldwell
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Endogenous processing and presentation of T-cell epitopes from Chlamydia trachomatis with relevance in HLA-B27-associated reactive arthritis.

Authors:  Juan J Cragnolini; Noel García-Medel; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2009-05-13       Impact factor: 5.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.